Exploratory Clinical Study of MT-2301 in Healthy Infants (Phase 2)

Trial Profile

Exploratory Clinical Study of MT-2301 in Healthy Infants (Phase 2)

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2015

At a glance

  • Drugs Haemophilus b CRM197 conjugate vaccine (HibTITER) (Primary) ; DTP poliovirus vaccine; Hib vaccine conjugate
  • Indications Haemophilus infections
  • Focus Pharmacodynamics
  • Sponsors Mitsubishi Tanabe Pharma Corporation
  • Most Recent Events

    • 16 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 08 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top